{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:58:58Z","timestamp":1790387938833,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vitrectomy with epiretinal membrane (ERM) and internal limiting membrane (ILM) peeling may provide anatomical and functional benefit in selected eyes with refractory diabetic macular edema, but predictors of postoperative outcome remain incompletely defined. This study aimed to evaluate the anatomical and functional outcomes of pars plana vitrectomy (PPV) combined with ERM and ILM peeling in eyes with diabetic macular edema (DME) and to investigate the prognostic value of preoperative OCT biomarkers for postoperative outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty eyes of 30 patients with DME refractory to repeated intravitreal anti-VEGF and\/or corticosteroid therapy underwent 25-gauge PPV with ERM and ILM peeling. Best-corrected visual acuity (BCVA), central subfield thickness (CST), postoperative treatment requirement, and preoperative OCT biomarkers were evaluated. Associations between baseline OCT biomarkers and 12-month anatomical and functional outcomes were assessed using unadjusted analyses and multivariable regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mean BCVA improved from 1.08\u2009\u00b1\u20090.52 logMAR at baseline to 0.65\u2009\u00b1\u20090.42 logMAR at 12 months (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), while mean CST decreased from 533.80\u2009\u00b1\u2009100.31\u00a0\u03bcm to 261.23\u2009\u00b1\u200934.31\u00a0\u03bcm (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Baseline DRIL was independently associated with worse 12-month BCVA (\u03b2\u2009=\u20090.399, 95% CI 0.035\u20130.762;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.032). Eyes with intact EZ showed greater numerical visual improvement than those with EZ disruption, although the difference was not statistically significant (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.093). Absence of baseline HRF was associated with greater CST reduction in the unadjusted analysis (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), but HRF was not independently associated with 12-month CST (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.309). During postoperative follow-up, 22 eyes (73.3%) required no additional intravitreal treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PPV with ERM and ILM peeling was associated with significant anatomical and functional improvement in selected eyes with refractory DME. Among the preoperative OCT biomarkers evaluated, DRIL showed the most consistent prognostic association with postoperative visual outcome. Preoperative assessment of retinal microstructure may provide complementary information for visual prognostication and patient counseling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-026-05352-0","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:25:24Z","timestamp":1790069124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative OCT biomarkers and surgical outcomes after vitrectomy with epiretinal membrane and internal limiting membrane peeling for refractory diabetic macular edema: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4183-3669","authenticated-orcid":false,"given":"Ozge","family":"Saritas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelda Yildiz","family":"Tasci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasin","family":"Toklu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"5352_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0161-6420(84)34337-8","volume":"91","author":"R Klein","year":"1984","unstructured":"Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology. 1984;91:1\u20139.","journal-title":"Ophthalmology"},{"key":"5352_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556\u201364. https:\/\/doi.org\/10.2337\/dc11-1909.","journal-title":"Diabetes Care"},{"key":"5352_CR3","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.ophtha.2013.02.034","volume":"120","author":"DM Brown","year":"2013","unstructured":"Brown DM, Nguyen QD, Marcus DM, et al. Long-term outcomes of ranibizumab therapy for diabetic macular edema. Ophthalmology. 2013;120:2013\u201322. https:\/\/doi.org\/10.1016\/j.ophtha.2013.02.034.","journal-title":"Ophthalmology"},{"key":"5352_CR4","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","volume":"117","author":"MJ Elman","year":"2010","unstructured":"Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117:1064\u201377. https:\/\/doi.org\/10.1016\/j.ophtha.2010.02.031.","journal-title":"Ophthalmology"},{"key":"5352_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00592-018-1151-x","volume":"55","author":"C Busch","year":"2018","unstructured":"Busch C, Zur D, Fraser-Bell S, et al. Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema. Acta Diabetol. 2018;55:789\u201396. https:\/\/doi.org\/10.1007\/s00592-018-1151-x.","journal-title":"Acta Diabetol"},{"key":"5352_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/jamaophthalmol.2017.4914","volume":"136","author":"RK Maturi","year":"2018","unstructured":"Maturi RK, Glassman AR, Liu D, et al. Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients with Persistent Diabetic Macular Edema. JAMA Ophthalmol. 2018;136:29\u201338. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.4914.","journal-title":"JAMA Ophthalmol"},{"key":"5352_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamaophthalmol.2017.6565","volume":"136","author":"NM Bressler","year":"2018","unstructured":"Bressler NM, Beaulieu WT, Glassman AR, et al. Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema with Vision Impairment. JAMA Ophthalmol. 2018;136:257\u201369. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.6565.","journal-title":"JAMA Ophthalmol"},{"key":"5352_CR8","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/s0161-6420(92)31901-3","volume":"99","author":"H Lewis","year":"1992","unstructured":"Lewis H, Abrams GW, Blumenkranz MS, et al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99:753\u20139. https:\/\/doi.org\/10.1016\/s0161-6420(92)31901-3.","journal-title":"Ophthalmology"},{"issue":"11","key":"5352_CR9","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.3390\/jcm14113686","volume":"14","author":"S El-Khoury","year":"2025","unstructured":"El-Khoury S, Ngo C, Muraine M, et al. Pars Plana Vitrectomy and ILM Peeling for Refractory Diabetic Macular Edema Without Vitreomacular Traction. J Clin Med. 2025;14(11):3686. https:\/\/doi.org\/10.3390\/jcm14113686.","journal-title":"J Clin Med"},{"key":"5352_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00417-008-0980-7","volume":"247","author":"E Stef\u00e1nsson","year":"2009","unstructured":"Stef\u00e1nsson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol. 2009;247:147\u201363. https:\/\/doi.org\/10.1007\/s00417-008-0980-7.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5352_CR11","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480\u20137. https:\/\/doi.org\/10.1056\/NEJM199412013312203.","journal-title":"N Engl J Med"},{"key":"5352_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s004170000251","volume":"239","author":"EC La Heij","year":"2001","unstructured":"La Heij EC, Hendrikse F, Kessels AG, et al. Vitrectomy results in diabetic macular oedema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol. 2001;239:264\u201370. https:\/\/doi.org\/10.1007\/s004170000251.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5352_CR13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1001\/jamaophthalmol.2014.2350","volume":"132","author":"JK Sun","year":"2014","unstructured":"Sun JK, Lin MM, Lammer J, et al. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol. 2014;132:1309\u201316. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.2350.","journal-title":"JAMA Ophthalmol"},{"key":"5352_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ophtha.2017.08.031","volume":"125","author":"D Zur","year":"2018","unstructured":"Zur D, Iglicki M, Busch C, et al. OCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implant. Ophthalmology. 2018;125:267\u201375. https:\/\/doi.org\/10.1016\/j.ophtha.2017.08.031.","journal-title":"Ophthalmology"},{"key":"5352_CR15","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/IAE.0000000000001304","volume":"37","author":"S Vujosevic","year":"2017","unstructured":"Vujosevic S, Bini S, Torresin T, et al. Hyperreflective retinal spots in diabetic retinopathy. Retina. 2017;37:1092\u2013103. https:\/\/doi.org\/10.1097\/IAE.0000000000001304.","journal-title":"Retina"},{"issue":"1","key":"5352_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ophtha.2025.07.038","volume":"133","author":"K Nanji","year":"2026","unstructured":"Nanji K, Grad J, Hatamnejad A, et al. Baseline OCT Biomarkers Associated with Visual Acuity in Diabetic Macular Edema: A Systematic Review and Meta-analysis. Ophthalmology. 2026;133(1):75\u201390. https:\/\/doi.org\/10.1016\/j.ophtha.2025.07.038.","journal-title":"Ophthalmology"},{"issue":"2","key":"5352_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jcjo.2023.01.012","volume":"59","author":"SB Velaga","year":"2024","unstructured":"Velaga SB, Nittala MG, Alagorie AR, et al. OCT outcomes as biomarkers for disease status, visual function, and prognosis in diabetic macular edema. Can J Ophthalmol. 2024;59(2):109\u201318. https:\/\/doi.org\/10.1016\/j.jcjo.2023.01.012.","journal-title":"Can J Ophthalmol"},{"key":"5352_CR18","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1097\/IAE.0000000000000497","volume":"35","author":"K Kumagai","year":"2015","unstructured":"Kumagai K, Hangai M, Ogino N, et al. Effect of internal limiting membrane peeling on long-term visual outcomes for diabetic macular edema. Retina. 2015;35:1422\u20138. https:\/\/doi.org\/10.1097\/IAE.0000000000000497.","journal-title":"Retina"},{"key":"5352_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajo.2016.12.006","volume":"175","author":"A Govetto","year":"2017","unstructured":"Govetto A, Lalane RA 3rd, Sarraf D, Figueroa MS, Hubschman JP. Insights Into Epiretinal Membranes: Presence of Ectopic Inner Foveal Layers and a New Optical Coherence Tomography Staging Scheme. Am J Ophthalmol. 2017;175:99\u2013113. https:\/\/doi.org\/10.1016\/j.ajo.2016.12.006.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"5352_CR20","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.3390\/jcm12062297","volume":"12","author":"S Ranno","year":"2023","unstructured":"Ranno S, Vujosevic S, Mambretti M, et al. Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema. J Clin Med. 2023;12(6):2297. https:\/\/doi.org\/10.3390\/jcm12062297.","journal-title":"J Clin Med"},{"issue":"21","key":"5352_CR21","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.12998\/wjcc.v12.i21.4491","volume":"12","author":"L Wang","year":"2024","unstructured":"Wang L, Chen CJ, Wang ML, et al. Effects of vitrectomy combined with internal limiting membrane peeling in patients with diabetic macular edema. World J Clin Cases. 2024;12(21):4491\u20138. https:\/\/doi.org\/10.12998\/wjcc.v12.i21.4491.","journal-title":"World J Clin Cases"},{"key":"5352_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0002-9394(00)00472-4","volume":"130","author":"SD Pendergast","year":"2000","unstructured":"Pendergast SD, Hassan TS, Williams GA, et al. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol. 2000;130:178\u201386. https:\/\/doi.org\/10.1016\/S0002-9394(00)00472-4.","journal-title":"Am J Ophthalmol"},{"key":"5352_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/s0002-9394(14)72018-5","volume":"122","author":"N Tachi","year":"1996","unstructured":"Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol. 1996;122:258\u201360. https:\/\/doi.org\/10.1016\/s0002-9394(14)72018-5.","journal-title":"Am J Ophthalmol"},{"key":"5352_CR24","first-page":"284","volume":"31","author":"E Stef\u00e1nsson","year":"1990","unstructured":"Stef\u00e1nsson E, Novack RL, Hatchell DL. Vitrectomy prevents hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 1990;31:284\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5352_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/112067210401400209","volume":"14","author":"M Stefaniotou","year":"2004","unstructured":"Stefaniotou M, Aspiotis M, Kalogeropoulos C, et al. Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal. Eur J Ophthalmol. 2004;14:137\u201343. https:\/\/doi.org\/10.1177\/112067210401400209.","journal-title":"Eur J Ophthalmol"},{"key":"5352_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/01.iae.0000249390.61854.d5","volume":"27","author":"A Yanyali","year":"2007","unstructured":"Yanyali A, Horozoglu F, Celik E, et al. Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Retina. 2007;27:557\u201366. https:\/\/doi.org\/10.1097\/01.iae.0000249390.61854.d5.","journal-title":"Retina"},{"key":"5352_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10792-006-0008-4","volume":"26","author":"M Bahadir","year":"2005","unstructured":"Bahadir M, Ertan A, Mertoglu O. Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema. Int Ophthalmol. 2005;26:3\u20138. https:\/\/doi.org\/10.1007\/s10792-006-0008-4.","journal-title":"Int Ophthalmol"},{"key":"5352_CR28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00417-006-0456-6","volume":"245","author":"A Kumar","year":"2007","unstructured":"Kumar A, Sinha S, Azad R, et al. Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2007;245:360\u20138. https:\/\/doi.org\/10.1007\/s00417-006-0456-6.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5352_CR29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00417-003-0849-8","volume":"242","author":"P Dillinger","year":"2004","unstructured":"Dillinger P, Mester U. Vitrectomy with removal of the internal limiting membrane in chronic diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol. 2004;242:630\u201337. https:\/\/doi.org\/10.1007\/s00417-003-0849-8.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5352_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ajo.2004.09.076","volume":"139","author":"FM Recchia","year":"2005","unstructured":"Recchia FM, Ruby AJ, Carvalho Recchia CA. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol. 2005;139:447\u201354. https:\/\/doi.org\/10.1016\/j.ajo.2004.09.076.","journal-title":"Am J Ophthalmol"},{"key":"5352_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00417-004-0958-z","volume":"243","author":"BJ Rosenblatt","year":"2005","unstructured":"Rosenblatt BJ, Shah GK, Sharma S, et al. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol. 2005;243:20\u20135. https:\/\/doi.org\/10.1007\/s00417-004-0958-z.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"5352_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/vision9010004","volume":"9","author":"S Chaturvedi","year":"2025","unstructured":"Chaturvedi S, Paul A, Singh S, et al. The Ellipsoid Zone Is a Structural Biomarker for Visual Outcomes in Diabetic Macular Edema and Macular Hole Management. Vis (Basel). 2025;9(1):4. https:\/\/doi.org\/10.3390\/vision9010004.","journal-title":"Vis (Basel)"},{"issue":"4","key":"5352_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000485852","volume":"239","author":"K Hatz","year":"2018","unstructured":"Hatz K, Ebneter A, Tuerksever C, et al. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features. Ophthalmologica. 2018;239(4):205\u201314. https:\/\/doi.org\/10.1159\/000485852.","journal-title":"Ophthalmologica"},{"key":"5352_CR34","doi-asserted-by":"publisher","first-page":"8117650","DOI":"10.1155\/2021\/8117650","volume":"2021","author":"LJ Kessler","year":"2021","unstructured":"Kessler LJ, Auffarth GU, Bagautdinov D, et al. Ellipsoid Zone Integrity and Visual Acuity Changes during Diabetic Macular Edema Therapy: A Longitudinal Study. J Diabetes Res. 2021;2021:8117650. https:\/\/doi.org\/10.1155\/2021\/8117650.","journal-title":"J Diabetes Res"},{"issue":"9","key":"5352_CR35","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.4103\/IJO.IJO_800_25","volume":"73","author":"A Tripathi","year":"2025","unstructured":"Tripathi A, Gaur S, Agarwal R, et al. Disorganization of retinal inner layers as an optical coherence tomography biomarker in diabetic retinopathy: A review. Indian J Ophthalmol. 2025;73(9):1245\u201350. https:\/\/doi.org\/10.4103\/IJO.IJO_800_25.","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"5352_CR36","doi-asserted-by":"publisher","first-page":"100168","DOI":"10.1016\/j.apjo.2025.100168","volume":"14","author":"Y Shu","year":"2025","unstructured":"Shu Y, Zhang C, Bi Y, Zhang J. Hyperreflective foci and subretinal fluid predicts microglia activation involved in the breakdown of outer blood-retinal barrier in treatment-na\u00efve patients with diabetic macular edema. Asia Pac J Ophthalmol. 2025;14(5):100168. https:\/\/doi.org\/10.1016\/j.apjo.2025.100168.","journal-title":"Asia Pac J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-05352-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05352-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05352-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:02:49Z","timestamp":1790384569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-05352-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5352"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-05352-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"7 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Ethics committee approval was obtained from the Ankara Bilkent City Hospital Ethics Committee (Approval number: TABED 2-26-1899). Due to the retrospective nature of the study, the requirement for informed consent was waived by the Ethics Committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"598"}}